Document:

Exhibit

Exhibit 10.1

September 24, 2018

Mr. Art A. Garcia
Address on file with the Company

		
	Re:
	CFO Transition and Retention Agreement

Dear Art:
This Transition and Retention Agreement (this “Agreement”) sets forth the understanding between you and Ryder System, Inc. (the “Company”) regarding your continued employment as Chief Financial Officer of the Company and your planned retirement and transition.  On behalf of the Board of Directors of the Company, I want to thank you for your years of leadership and your willingness to provide continued service as Chief Financial Officer and then in the role of Special Advisor.  
		
	1.
	Continued Service as Chief Financial Officer and Special Advisor

(a)Transition.  Your service as Executive Vice President and Chief Financial Officer (“CFO”) of the Company will continue until the earlier of (1) the date your successor to the position of CFO of the Company commences employment with the Company and (2) April 30, 2019.  After a successor commences employment (if prior to April 30, 2019), you will continue to be employed by the Company and serve as a Special Advisor to the Company’s Chief Executive Officer (the “CEO”).  As Special Advisor, your duties may include supporting and providing guidance to the CEO and new CFO and such other reasonable duties as assigned to you by the CEO.  

(b)Retirement Date.  Your service as an employee with the Company will end on April 30, 2019 (the “Retirement Date”).  

		
	2.
	Compensation 

(a)Salary.  From now until the Retirement Date (the “Transition Period”), you will continue to receive your current salary.

(b)Annual Bonus.  The execution of this Agreement will not affect your eligibility to receive an annual bonus for 2018, which will be paid based on actual performance when 2018 bonuses are generally paid to senior executives of the Company subject to and in accordance with the terms of such annual bonus program.  You will not be eligible to receive a bonus for fiscal year 2019 other than in accordance with the Amended and Restated Severance Agreement between you and the Company dated February 27, 2017 (your “Severance Agreement”).

(c)Long-Term Incentive Cash and Equity Awards.  All of your outstanding long-term incentive awards, including stock options, restricted stock, performance-based restricted stock rights and performance-based cash awards, will continue to vest, be earned and be payable (and, for stock options, be exercisable) subject to and in accordance with their current terms. You will not receive any further equity or long-term incentive cash awards under the Company’s long-term incentive plans.    

(d)Benefit Plans and Programs.  During the Transition Period, subject to your continued service, you will continue to remain eligible to participate in the Company employee benefit plans and programs in which you currently participate on the same terms and conditions as other senior executives of the Company.

(e)Existing Severance Entitlements.  As consideration of your agreement to continue to serve the Company as Chief Financial Officer and thereafter as Special Advisor, subject to your continued employment through March 1, 2019, you will be entitled to receive the benefits under your Severance Agreement payable upon an Involuntary Termination without Cause not due to a Change of Control, subject to the existing terms and conditions of your Severance Agreement.  The execution of this Agreement does not otherwise affect the benefits you are entitled to under your Severance Agreement.  Your benefits under your Severance Agreement will become payable in accordance with the terms therein.  For the avoidance of do

Exhibit 10.1

ubt, your employment with the Company continues to be at-will, and if you voluntarily terminate your employment before March 1, 2019, you will only be entitled to receive the benefits under your Severance Agreement payable upon a voluntary termination without Good Reason.  

		
	3.
	Ongoing Obligations and Other Terms

(a)Ongoing Obligations.  You agree and acknowledge that your obligations under your Severance Agreement, including Section 5(f) (Additional Terms) and Section 10 (Restrictive Covenants), will continue in accordance with their terms.  You acknowledge the potential restrictions on your future employment imposed by such provisions and covenants are reasonable in both duration and geographic scope and in all other respects.

(b)Tax Withholding.  The Company may withhold from any and all amounts payable under this Agreement such federal, state and local taxes as may be required to be withheld pursuant to any applicable law or regulation. 

(c)Section Headings.  The section headings used in this Agreement are included solely for convenience and will not affect, or be used in connection with, the interpretation of this Agreement. 

(d)Governing Law.  The validity, interpretation, construction, and performance of this Agreement will be governed by the laws of the State of Florida without regard to its conflicts of law principles. You and the Company agree that any suit, action or other legal proceeding that is commenced to resolve any matter arising under or relating to any provision of this Agreement will be commenced only in a court of the State of Florida (or, if appropriate, a federal court located within the State of Florida), in either case located in Miami, Florida, and the parties consent to the jurisdiction of such court. You and the Company accept the exclusive jurisdiction and venue of those courts for the purpose of any such suit, action or proceeding. You and the Company each hereby irrevocably waive any right to a trial by jury in any action, suit or other legal proceeding arising under or relating to any provision of this Agreement. 

(e)Severability; Counterparts.  The provisions of this Agreement will be deemed severable, and the invalidity or unenforceability of any provision will not affect the validity or enforceability of the other provisions hereof.  This Agreement may be executed in several counterparts, each of which will be deemed to be an original but all of which together will constitute one and the same instruments. 

(f)Section 409A of the Code.  This Agreement is intended to comply with or be exempt from the requirements of Section 409A of the Internal Revenue Code of 1986 (“Section 409A”) with respect to amounts, if any, subject thereto and shall be interpreted, construed and performed consistent with such intent. If and to the extent that any payment under this Agreement is determined by the Company to constitute “non-qualified deferred compensation” subject to Section 409A (because a payment is not a “short-term deferral” and not an involuntary severance payment under Treas. Reg. §1.409A-1(b)(9)(iii)) and that is payable to you by reason of your termination of employment, then (1) such payment or benefit shall be made or provided to you only upon a “separation from service” as defined for purposes of Section 409A under applicable regulations and (2) if you are a “specified employee” (within the meaning of Section 409A and as determined by the Company), such payment will not be made or provided before the date that is six months after the date of your separation from service (or your earlier death or a change in ownership or effective control within the meaning of Section 409A). To the extent applicable, each payment under this Agreement shall be treated as a separate payment for purposes of Section 409A.
*   *   *
Thank you again for your dedicated leadership and your continued service.
 [Remainder of Page Left Intentionally Blank]

Exhibit 10.1

To indicate agreement with the foregoing, please sign and return this Agreement to me.
                
On behalf of the Company:
By:    /s/ Robert E. Sanchez        
Name:    Robert E. Sanchez
Title:    Chair of the Board and 
Chief Executive Officer

Accepted and Agreed:
/s/  Art  A. Garcia    
Name:    Art A. Garcia

Date:    September 24, 2018EXHIBIT 10.1

      

      

      Joint Venture Agreement

      

      

      This Joint Venture Agreement ("Agreement"), made on September 5, 2018 by and between QUANTA, of 3606 W MAGNOLIA BLVD, BURBANK, California 91505 and 2664431
          Ontario Inc. (Quanta Canada) of 11 BUTTERMILL AVE, CONCORD, ONTARIO, CANADA L4K 3X1. The parties are hereinafter sometimes referred to together as the "Joint Venturers" or the "Parties" and individually as a "Joint Venturer" or "Party."

      

      

      The Parties wish to establish a Joint Venture for the purpose set forth below (the "Joint Venture"); and

      

      

      The Parties wish to enter into an agreement to carry out the purpose of the Joint Venture and to define the respective rights and obligations of the Parties
          with respect to the Joint Venture.

      

      

      Therefore, in consideration of the mutual promises, covenants, warranties and conditions herein, the Joint Venturers agree as follows:

      

      

      Name. The parties hereby form and establish a Joint Venture to be
          conducted under the name of Quanta Canada, (hereinafter referred to as the "Joint Venture"). The Joint Venturers agree that the legal title to the Joint Venture property and assets, including the Joint Venture itself, shall remain in the name of
          the Joint Venture.

      

      

      Place of Business & Term. The principal place of business of
          the Joint Venture shall be located at 11 BUTTERMILL AVE, CONCORD, ONTARIO, CANADA L4K 3X1. The term of the Joint Venture shall commence on the execution date hereof and shall continue for 30 Months provided, however, that the Joint Venture shall
          be dissolved prior to such date upon the sale or disposal of the Joint Venture and the payment or satisfaction of all debts of the Joint Venture.

      

      

      Purpose and Exclusivity. The Joint Venturers form this Joint
          Venture to: To extend the Quanta brand, technology and product lines into the Canadian markets. To the extent set forth in this Agreement, each of the Joint Venturers shall own an undivided fractional part in the business. The Joint Venture shall
          not engage in any other new associated business or activity without the written consent of the Joint Venturers. Venturers mutually agree to extend exclusivity in the nation of Canada for a period of one year from the execution date of this
          agreement. Future grant of exclusivity will be determined by performance metrics that shall be set and agreed upon at a later date.

      

      

      First-Look Rights. Quanta agrees to extend Quanta Canada rights to
          first look upon any third party offer to buy-out the main corporation as long as Quanta Canada remains in good standing with the terms and conditions of the agreement.

      

      

      
        1

        
          

      

      
        Capital. Separate capital accounts shall be maintained for each
            Joint Venturer and shall consist of the sum of its contributions to the capital of the Joint Venture plus its share of the profits of the Joint Venture, less its share of any losses of the Joint Venture, and less any distributions to or
            withdrawals made by or attributed to it from the Joint Venture. The initial contributions from each of the Joint Venturers, for the purpose of this Joint Venture, is the sum set after the name of each Joint Venturer as follows:

      

       

        

      Quanta $302,775.00 (current investment in new machinery)

      Canada Corp $302,775.00 (licensing fee due upon execution)

      

      

      The Joint Venturers shall make such other capital contributions required to enable the Joint Venture to carry out its purposes as set forth herein as the
          Joint Venturers may mutually agree upon. The Joint Venturers shall arrange for or provide any financing as may be required by the Joint Venture for carrying out the purposes of the Joint Venture. The terms and conditions of all such loans shall
          be subject to prior approval of the Joint Venturers. The Joint Venturers shall endorse, assume, or guarantee such obligations of the Joint Venture as the Joint Venturers may mutually agree upon.

      

      

      Percentage Interest In The Joint Venture. The respective percentage
          interest in the Joint Venture owned by each Joint Venturer, respectively, is as follows:

      

      

      Quanta 50

      Canada Corp 50

      

      

      Profits. The net profits as they accrue for the term of this
          Agreement, or so long as the Joint Venturers are the owners in common of the business interest, shall be distributed between the Joint Venturers, based on the respective percentage interest in the Joint Venture owned by each Joint Venturer as
          follows:

      

      

      Quanta 50

      Canada Corp 50

      

      

      Expenses of Venture. All losses and disbursements in acquiring,
          holding and protecting the business interest and the net profits shall, during the period of the venture, be paid by the Joint Venturers, in the ratio which the contribution of each Joint Venturer bears to the total contributions upon consent of
          both Venturers.

      

      

      Duties of Joint Venturers. The duties of Quanta are: Quanta shall
          provide a turnkey system for implementation and commercialization of its core technology and all its uses. This shall include providing a simple, proven model for formulation, product manufacturing and licensing revenue generation. The company
          will provide global marketing and educational content and marketing. Quanta will also provide all hardware and packaging for future production of Quanta branded products.

      

      

      The duties of Quanta Canada are: shall focus on revenue generation via regional, national and international distribution and exportation.

      

      

      
        2

        
          

      

      Powers of Joint Venturers. The following powers may be exercised
          only upon the consent of the Joint Venturers:

      

      

      (a) The power to borrow money on the general credit of the Joint Venture in any amount, or to create, assume, or incur any indebtedness to any person or
          entity;

      (b) The power to make loans in any amount, to guarantee obligations of any person or entity, or to make any other pledge or extension of credit;

      (c) The power to purchase or otherwise acquire any other property except in the ordinary course of business of the Joint Venture;

      (d) The power to sell, encumber, mortgage or refinance any loan or mortgage on any of the Joint Venture property;

      (e) The power to confess any judgment against the Joint Venture, or to create, assume, incur or consent to any charge (including any deed of trust, pledge,
          encumbrance or security interest of any kind) upon any property or assets of the Joint Venture;

      (f) The power to spend any renovation or remodeling funds or to make any other expenditures except for routine day-to-day maintenance and operation of the
          Joint Venture.

      

      

      Confidential Information. "Confidential Information" means
          nonpublic information that (a) the disclosing Party designates as confidential, or (b) information which, under the circumstances surrounding disclosure, ought to be treated as confidential. Confidential Information may include, without
          limitation, Technology, Technology Improvements, Derivative Works, Intellectual Property Rights, Marketing Materials, ideas, know-how, methods, formulae, processes, designs, apparatus, devices, techniques, systems, flow charts, sketches,
          photographs, plans, drawings, specifications, computer programs or software, samples, studies, findings, data, reports, projections, plant and equipment expansion plans, lists or identities of employees, customers or X6Ds, financial statements or
          other financial information, pricing information, cost and expense information, product development and marketing plans, compositions of matter, discoveries and inventions (whether or not patentable), works of authorship (whether or not protected
          under copyright laws), information, algorithms, procedures, notes, summaries, descriptions, results and the like.

      

      

      Derivative Works. "Derivative Works" means works that are based
          upon one or more preexisting works, such as: (a) for copyrightable or copyrighted material, any translation, portation, modification, correction, addition, extension, upgrade, improvement, compilation, abridgment, revision or other form in which
          such material may be recast, transformed, or adapted; (b) for patentable or patented material, any improvement thereon; and (c) for material that is protected by trade secret, any new material derived from such existing trade secret material,
          including new material that may be protected by any of copyright, patent, and trade secret.

      

      

      Intellectual Property Rights. "Intellectual Property Rights" means
          any and all patent, copyright, trademark, trade secret, know-how, trade dress or other intellectual or industrial property rights or proprietary rights (including, without limitation, all claims and causes of action for infringement,
          misappropriation or violation thereof and all rights in any registrations, applications and renewals thereof), whether existing now or in the future, whether worldwide or in individual countries or political subdivisions thereof, or regions,
          including, without limitation, the United States.

      

      

      
        3

        
          

      

      Technology. "Technology" means materials, packaging, products,
          know-how and methods of manufacturing thereof as provided by a Party herein, and including all Intellectual Property Rights embodied therein and any Derivative Works thereof. Technology further means, without limitation, any designs, materials,
          methods, formulae, processes, technology, apparatus, devices, techniques, systems, flow charts, sketches, photographs, plans, drawings, specifications, proprietary information, know-how, trade secrets, computer programs or software, samples,
          studies, findings, data, reports, projections, manufacturing specifications and methods, testing specifications and methods, pricing information, cost and expense information, product development and marketing plans, compositions of matter,
          discoveries and inventions (whether or not patentable), works of authorship (whether or not protected under copyright laws), information, algorithms, procedures, notes, summaries, descriptions and development results related to any materials,
          packaging, products, know-how and methods of manufacturing thereof.

      

      

      Technology Improvements. "Technology Improvements" means any
          proprietary information, know-how, trade secrets, programs, designs, processes, methods, formulae, compositions of matter, documents, materials, technology, data, Intellectual Property Rights, or Derivative Works in developments and/or
          conceptions created, obtained or developed by either Party alone (including through the efforts of any independent contractor or affiliate of that Party) or together with the other Party that: (a) are based on, derived from or are direct
          improvements to Technology, (b) can be used in or in the production of Technology, or (c) provide alternatives for use in the production of Technology that, if so used, reasonably would: (i) add Technology capability or increase Technology
          efficiency or quality, (ii) reduce Technology manufacturing or Technology costs, and/or (iii) facilitate the manufacturing of Technology.

      

      

      Treatment of Proprietary and Confidential Information.

      

      

      1. In connection with the performance of this Agreement, each Party contemplates the
          disclosure by it of certain Confidential Information to the other Party. Each Party considers its Confidential Information to be an asset of substantial commercial value, having been developed at considerable expense, but will disclose such
          information to the other Party under the terms and conditions of this Agreement.

      

      

      (a) During the Term and continuing thereafter for 30 months from the termination or expiration of the Agreement, the Party receiving Confidential
          Information ("Receiving Party") from the disclosing Party ("Disclosing Party") shall (i) treat all Confidential Information disclosed by the Disclosing Party as secret and confidential and shall not disclose all or any portion of the Confidential
          Information to any other Person, except as provided in section 1.1(b), (ii) not use any of such Confidential Information except in the performance of the Receiving Party's covenants and obligations or otherwise as contemplated under this
          Agreement, and (iii) restrict access to Confidential Information to the Receiving Party's employees (including contractors, accountants and counsel and similar representatives) who have a need to know such information in connection with the
          performance of the Receiving Party's obligations and covenants under this Agreement and shall be responsible to ensure that such employees maintain the terms of confidentiality and nonuse as required in this Agreement.

       

        

      
        4

        
          

      

      (b) In the event that either Party desires to use a third party service provider ("Service Provider"), including, for example, an engineering design firm or
          a contract manufacturer, to develop or produce the Product using Technology or Technology Improvements, all Parties to this Agreement must first enter into at least an acceptable non-disclosure and technology ownership agreement with the Service
          Provider. Neither Party to this Agreement may disclose any Confidential Information to a Service Provider unless (i) both Parties to this Agreement have individually entered into a non-disclosure agreement with the Service Provider and (ii) the
          Service Provider has a presence in the United States and is able to be served legal documents in the United States or agrees, in writing, that it can be served and that United States Courts have personal jurisdiction over the Service Provider.

      

      

      2. Notwithstanding anything to the contrary herein, Confidential Information shall not include any information that: (a) is presently in the Receiving
          Party's possession, provided that such information has not been obtained from the Disclosing Party and that such possession can be demonstrated by the Receiving Party's written records; (b) is, or becomes, generally available to the public
          through no act or omission of the Receiving Party; (c) is received by the Receiving Party in written form from a third party having no binding obligation to keep such information confidential; or (d) is required to be disclosed by law, upon the
          advice of legal counsel.

      

      

      3. Specific Confidential Information shall not be deemed to be available to the public or in the possession of the Receiving Party merely because it is
          embraced by more general information so available or in said Receiving Party's possession, nor shall a combination or aggregation of features which form confidential information be deemed to be non-confidential merely because the individual
          features, without being combined or aggregated, are non-confidential.

      

      

      4. Each of the Parties hereby agrees that all written or other tangible forms of Confidential Information (including any materials generated by the
          Receiving Party related to any Confidential Information) shall be and remain the property of its owner and shall be promptly returned to the owner upon the written request of the owner.

      

      

      5. Neither the Agreement nor the disclosure of any information by the Disclosing Party shall be deemed to constitute by implication or otherwise, a vesting
          of any title or interest or a grant of any license, immunity or other right to the Receiving Party with regard to the Confidential Information. Additionally, except as expressly provided in this Agreement, the execution of the Agreement shall not
          operate, directly or indirectly, to grant to either Party any rights under any patent, trade secret or know-how now or hereafter owned by or licensed to the other Party.

      

      

      6. Each Party warrants that it is the rightful owner of the Confidential Information to be disclosed under this Agreement and that it has the lawful right
          to make such disclosure.

      

      

      7. In the event that the Receiving Party or any of its representatives are requested or required to disclose Confidential Information pursuant to a subpoena
          or an order of a court or government agency, the Receiving Party shall (a) promptly notify the Disclosing Party of the existence, terms and circumstances surrounding the governmental request or requirements; (b) consult with the Disclosing Party
          on the advisability of taking steps to resist or narrow the request; (c) if disclosure of Confidential Information is required, furnish only such portion of the Confidential Information as the Receiving Party is advised by counsel is legally
          required to be disclosed; and (d) cooperate with the Disclosing Party in its efforts to obtain an order or other reliable assurance that confidential treatment be accorded to that portion of the Confidential Information that is required to be
          disclosed.

      

      

      
        5

        
          

      

      Because money damages may not be a sufficient remedy for any breach of this Section of the Agreement by the Receiving Party, the Disclosing Party shall be
          entitled to seek equitable relief, including injunction and specific performance, as a remedy for any such breach of this Section. Such remedy shall not be deemed to be the exclusive remedy for a breach of this Section of the Agreement by the
          Receiving Party, but shall be in addition to all other remedies available at law or equity to the Disclosing Party. In the event of litigation relating to the Agreement, if a court of competent jurisdiction determines that the Receiving Party has
          breached this Section of the Agreement, then the Receiving Party shall be liable and pay to the Disclosing Party the reasonable attorneys' fees, court costs and other reasonable expenses of litigation, including any appeal therefrom. The
          Receiving Party further agrees to waive any requirement for the posting of a bond in connection with any such equitable relief.

      

      

      No Liability to Third Parties. The debts, obligations and
          liabilities of either Joint Venturer, whether arising in contract, tort or otherwise, shall be solely the debts, obligations and liabilities of such Joint Venturer, and no other Party shall be obligated for any such debt, obligation or liability
          of such Joint Venturer solely by reason of being a party to this Agreement or an equity holder of a JV Company.

      

      

      Deadlock. In the event the Joint Venturers are divided on a
          material issue and cannot agree on the conduct of the business and affairs of the Joint Venture, then a deadlock between the Joint Venturers shall be deemed to have occurred. Upon the occurrence of a deadlock, one Joint Venturer (hereinafter
          referred to as the "Offeror") may elect to purchase the Joint Venture interest of the other Joint Venturer (hereinafter referred to as the "Offeree") at a price calculated as the Offeree's percentage interest in a total purchase price for all of
          the assets of the Joint Venture. The Offeror shall notify the Offeree in writing of the offer to purchase, stating the total purchase price for all of the assets of the Joint Venture, and the price offered for the Offeree's Joint Venture interest
          expressed as the Offeree's percentage interest in the Joint Venture assets multiplied by the total purchase price for all of the assets of the Joint Venture. The Offeree shall have the right to buy the interest of the Offeror at the designated
          price and terms, or to sell the Offeree's interest to the Offeror at the designated price and terms, whichever the Offeree may elect. The offer, when made by the Offeror, is irrevocable for thirty (30) days. The Offeree shall have ten (10) days
          from the receipt of such offer to make its election, that is, either to buy such interest of the Offeror or to sell its own interest, which shall be made in writing executed by the Offeree and stating the nature of the election. A Joint Venturer
          which is obligated to purchase the interest of another Joint Venturer pursuant to the provisions hereof shall have twenty (20) days from the date of receipt of the written election from such other Joint Venturer to pay the designated price and
          satisfy the terms of such purchase. Should the Joint Venturer who has received an offer to sell or buy fail to make the election required herein in a timely fashion, then such non-responding party shall be deemed to have elected and agreed to
          sell or buy, as the case may be, according to the terms of the offer.

      

      

      Legal Title to the Joint Venture. The Joint Venturers agree that
          the legal title to the Joint Venture property and assets, including the Joint Venture itself, shall remain in the name of the Joint Venture. Transfers Of Joint Venturers' Interests. Except as otherwise expressly permitted herein, no Joint
          Venturer may sell, transfer, assign or encumber its interest in the Joint Venture, or admit additional Joint Venturers, without the prior written consent of the other Joint Venturer.

       

        

      
        6

        
          

      

      Any attempt to transfer or encumber any interest in the Joint Venture in violation of this Section shall be null and void.

      

      

      The obligations and Rights of Transferees are as follows:

      (a)          Any person who acquires in any manner whatsoever any interest in the
          Joint Venture, irrespective of whether such person has accepted and adopted in writing the terms and provisions of this Agreement, shall be deemed by the acceptance of the benefit of the acquisition thereof to have agreed to be subject to and
          bound by all the obligations of this Agreement that any predecessor in interest of such a person was subject to or bound by;

      (b)          The person acquiring an interest in the Joint Venture shall have only
          such rights, and shall be subject to all of the obligations, as are set forth in this Agreement; and, without limiting the generality of the foregoing, such a person shall not have any right to have the value of its interest ascertained or
          receive the value of such interest or, in lieu thereof, profits attributable to any right in the Joint Venture, except as herein set forth.

      

      

      Termination. Upon the termination or dissolution of the Joint
          Venture, the Joint Venturers shall proceed to liquidate the Joint Venture, and all proceeds of such liquidation shall be applied and distributed in the manner set above according to the interests held by each party in the Joint Venture. A
          reasonable time shall be allowed for the orderly liquidation of the Joint Venture's assets in order to minimize losses normally attendant upon such liquidation.

      

      

      Notice. Any notices to be given under this Agreement by either
          party to the other may be effected either by personal delivery in writing or by mail, registered or certified, postage prepaid with return receipt requested. Mailed notices must be addressed to the addresses of the parties as they appear in the
          introductory paragraph of this Agreement. Each party may change its address by written notice in accordance with this paragraph. Notices delivered personally will be deemed communicated as of actual receipt; mailed notices will be deemed
          communicated as of 14 calendar days after mailing.

      

      

      Dispute Resolution. The Joint Venturers will attempt to resolve any
          dispute arising out of or relating to this Agreement through friendly negotiations amongst the Joint Venturers. If the matter is not resolved by negotiation, the Joint Venturers will resolve the dispute using the below Alternative Dispute
          Resolution (ADR) procedure.

      

      

      Any controversies or disputes arising out of or relating to this Agreement will be submitted to mediation in accordance with any statutory rules of
          mediation. If mediation is not successful in resolving the entire dispute or is unavailable, any outstanding issues will be submitted to binding arbitration under the rules of the American Arbitration Association. The arbitrator's award will be
          final, and judgment may be entered upon it by any court having proper jurisdiction.

      

      

      Miscellaneous Partition. The Joint Venturers hereby mutually waive
          any right of partition which they may have with respect to the Joint Venture and any noncash assets of the Joint Venture.

      

      

      Fees and Commissions. Each Joint Venturer hereby represents and
          warrants to the other that it has not incurred or obligated the Joint Venture for any brokerage, finder's or other similar fees or commissions in connection with the transactions covered by this Agreement or in connection with acquiring the Joint
          Venture or forming this Joint Venture. Each Joint Venturer hereby agrees to indemnify and hold harmless the other from and against all liabilities, costs, damages and expenses from any breach or alleged breach of the foregoing representation.

       

        

      
        7

        
          

      

      Waiver. Failure on the part of either Joint Venturer to complain of
          any act of the other Joint Venturer or to declare the other Joint Venturer in default, irrespective of how long such failure continues, shall not constitute a waiver by such Joint Venturer of its rights hereunder. No waiver of, or consent to, any
          breach or default shall be deemed or construed to be a waiver of, or consent to, any future breach or default.

      

      

      Severability. If any provision of this Agreement or the application
          thereof shall be determined by a court of competent jurisdiction to be invalid and unenforceable, the remainder of this Agreement and the application of the other provisions herein contained shall not be affected thereby, and all such other
          provisions shall remain effective and in force and shall be enforced to the fullest extent permitted by law.

      

      

      Binding Effect. This Agreement shall inure to the benefit of and be
          binding upon the Joint Venturers, and their heirs, successors and assigns.

      

      

      Duplicate Originals. This Agreement may be executed in duplicate,
          with each such duplicate to be considered an original for all purposes.

      

      

      Construction of Agreement. (a) The captions contained in this
          Agreement are inserted only as a matter of convenience and in no way define, limit, extend or describe the scope of this Agreement or the intent of any provision thereof. (b) As used herein, the word "person" shall include the individuals,
          corporations, partnerships and other entities of any type. In this Agreement, the use of any gender shall be applicable to all genders, and the singular shall include the plural, and the plural shall include the singular.

      

      

      Other Activities of Joint Venturers. Any Joint Venturer may engage
          in other business ventures of every nature and neither the Joint Venture nor the other Joint Venturer shall have any right in such independent ventures or the income and profits derived therefrom.

      

      

      Entire Agreement. This Agreement is intended by the Joint Venturers
          to be the final expression of their agreement and the complete and exclusive statement of the terms thereof, notwithstanding any representations or statements to the contrary heretofore made.

      

      

      Amendments. This Agreement may be amended by the Parties hereto at
          any time prior; provided, however, that any amendment must be by an instrument or instruments in writing signed and delivered on behalf of each of the Parties hereto.

      

      

      Governing Law; Consent to Personal Jurisdiction. This Agreement
          will be governed by the laws of the State of California without regard for conflicts of laws principles. Each Joint Venturer hereby expressly consents to the personal jurisdiction of the state and federal courts located in the State of California
          for any lawsuit filed there against any party to this Agreement by any other party to this Agreement concerning the Joint Venture or any matter arising from or relating to this Agreement.

       

        

      
        8

        
          

      

      In witness whereof, the Joint Venturers have signed and sealed this Agreement.

      

      

      Executed by the Joint Venturers named above with the intent of being legally bound.

      

      

      	
              Quanta

            	 
	 	 
	

            	 
	
              Eric Rice, CEO

            	 
	

            	 
	
              Date

            	 
	 	 
	
              2664431 Ontario Inc.

            	 
	 	 

      	

            	 
	
              Larry Pevato

            	 

      	

            	 
	
              Date

            	 

      

      

      
         

          

        9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}]]